Concepedia

Peter Bross

PB

7

Publications

1.5K

Citations

7

H-Index

2001

Active since

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Peter Bross is an author at United States Food and Drug Administration.

Publications per year

2001–2024

7

Publications

7

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.

Peter Bross, Julie Beitz, Gang Chen et al. · PubMed · 2001 · 861 citations

Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma

Peter Bross, Robert C. Kane, Ann T. Farrell et al. · Clinical Cancer Research · 2004 · 336 citations · Full text

Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.

John R. Johnson, Peter Bross, Martin H. Cohen et al. · PubMed · 2003 · 102 citations

FDA Drug Approval Summaries: Fulvestrant

Peter Bross, Martin H. Cohen, Grant A. Williams et al. · The Oncologist · 2002 · 84 citations · Full text

Fulvestrant in postmenopausal women with advanced breast cancer.

Peter Bross, Amy Baird, Gang Chen et al. · PubMed · 2003 · 52 citations

Rows per page

1–5 of 7